Substance Use Policy for the Biden Administration Event Description For twenty years, overdose deaths in the U.S. have sharply increased. In 2019, more than 70,000 Americans died of drug-related causes. Preliminary data suggests the COVID-19 pandemic is exacerbating this trend. To address the overdose crisis, President Biden released a plan for increased utilization of drug…
A Panel Discussion Event Description Can private companies effectively serve public health functions? During the COVID-19 pandemic, private companies have stepped into public health roles traditionally held by government agencies and non-governmental organizations. For example, Google and Apple collaborated to create exposure notification software that has been adopted domestically and internationally; Verily, the life sciences…
The Health Care System in the Age of COVID-19 Seminar Series Description On March 16, we hosted the final installment of the COVID-19 and the Law: Disruption, Impact, and Legacy Seminar Series. This seminar series considered the ethical, legal, regulatory, and broader social and institutional impacts that COVID-19 has had, as well as the longer-lasting…
A Holistic Examination of Pandemic Impact Event Description The COVID-19 pandemic has had disproportionate effects on the lives of persons with disabilities generally, and especially pronounced effects on specific subsets of this diverse population, including youth with intellectual, developmental, cognitive, and psychosocial disabilities. For example, a letter published recently in the American Journal of Psychiatry…
The Disparate Burdens of COVID-19 Seminar Series Description On March 3, we held the fourth installment of the COVID-19 and the Law: Disruption, Impact, and Legacy Seminar Series. This seminar series considered the ethical, legal, regulatory, and broader social and institutional impacts that COVID-19 has had, as well as the longer-lasting effects it may have…
The Use of Biotech in the COVID-19 Pandemic Seminar Series Description On February 23, we hosted the third installment of the COVID-19 and the Law: Disruption, Impact, and Legacy Seminar Series. This seminar series considered the ethical, legal, regulatory, and broader social and institutional impacts that COVID-19 has had, as well as the longer-lasting effects…
In light of the COVID-19 pandemic, this panel discussion will be held virtually, as an online webinar. To ensure that you will receive access to the livestream and be kept up to date on any changes to the event, register now. We will send out a link to the livestream of the event to all…
What COVID-19 Teaches Us About Health Justice and the Path Forward On February 16, we hosted the second installment of the COVID-19 and the Law: Disruption, Impact, and Legacy Seminar Series. This seminar series considered the ethical, legal, regulatory, and broader social and institutional impacts that COVID-19 has had, as well as the longer-lasting effects…
A Health Policy and Bioethics Consortium Event Description Minority racial and ethnic groups in the US have long experienced disparities in access to health care and worse health outcomes, undermining broader social, political, and economic equality. One component of these disparities are various stereotypes that affect how minority patients are perceived and treated. This session…
COVID-19’s Legacy & Evolving Legal Doctrines Seminar Series Description On February 2, we hosted the first installment of the COVID-19 and the Law: Disruption, Impact, and Legacy Seminar Series. This seminar series considered the ethical, legal, regulatory, and broader social and institutional impacts that COVID-19 has had, as well as the longer-lasting effects it may…
